These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1688482)

  • 1. Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes.
    Deedwania PC
    Am J Cardiol; 1990 Jan; 65(2):43A-50A; discussion 51A-52A. PubMed ID: 1688482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(2):37A-42A; discussion 51A-52A. PubMed ID: 2403734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sotalol Is More Powerful Than Propranolol in Suppressing Complex Ventricular Arrhythmias.
    Deedwania PC
    J Cardiovasc Pharmacol Ther; 1997 Oct; 2(4):259-272. PubMed ID: 10684467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials.
    Lazzara R
    Am J Cardiol; 1996 Aug; 78(4A):28-33. PubMed ID: 8780326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias.
    Cavusoglu E; Frishman WH
    Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.
    Hohnloser SH; Zabel M; van de Loo A; Klingenheben T; Just H
    Int J Cardiol; 1992 Dec; 37(3):283-91. PubMed ID: 1281807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sotalol versus class I and II antiarrhythmic agents.
    Hanyok JJ; MacNeil DJ
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():603-11. PubMed ID: 2275890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Singh BN; Deedwania P; Nademanee K; Ward A; Sorkin EM
    Drugs; 1987 Sep; 34(3):311-49. PubMed ID: 3315621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
    Kubac G; Klinke WP; Grace M
    Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration/response relations for the multiple antiarrhythmic actions of sotalol.
    Woosley RL; Barbey JT; Wang T; Funck-Brentano C
    Am J Cardiol; 1990 Jan; 65(2):22A-27A; discussion 35A-36A. PubMed ID: 2294688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity.
    Giorgi C; Nadeau R; Agha A; Primeau R; de Champlain J
    Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA; McGovern BA
    Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.